2.42
-0.06 (-2.42%)
-0.06 (-2.42%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.58
High
4.26
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.06 | -2.42% | 2.42 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.48 | 2.38 | 2.48 | 2.42 | 2.48 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.24 | 2.55 | 0.31 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,109 | 271,137 | $ 2.44 | $ 660,856 | - | 0.58 - 4.26 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:40:04 | formt | 400 | $ 2.42 | USD |
Period:
Draw Mode:
Outlook Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 420.13M | 173.61M | 101.57M | $ 8.15M | $ - | -0.99 | -11.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 30.00k | 6.10% |
Outlook Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.27 | 2.53 | 2.1554 | 2.39 | 518,914 | 0.15 | 6.61% |
| 1 Month | 2.45 | 2.675 | 2.1554 | 2.44 | 1,180,742 | -0.03 | -1.22% |
| 3 Months | 2.33 | 2.86 | 1.92 | 2.42 | 945,059 | 0.09 | 3.86% |
| 6 Months | 1.35 | 4.26 | 0.9285 | 2.27 | 2,842,968 | 1.07 | 79.26% |
| 1 Year | 1.65 | 4.26 | 0.58 | 1.84 | 2,194,009 | 0.77 | 46.67% |
| 3 Years | 5.60 | 20.00 | 0.4011 | 1.92 | 1,783,514 | -3.18 | -56.79% |
| 5 Years | 5.60 | 20.00 | 0.4011 | 1.92 | 1,783,514 | -3.18 | -56.79% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
